Idorsia Ltd
SIX:IDIA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Al-Razi Medical Company SJSC
SAU:9572
|
SA |
|
Electro Aco Altona SA
BOVESPA:EALT4
|
BR |
Idorsia Ltd
Other Current Assets
Idorsia Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Current Assets
CHf10.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Other Current Assets
$11.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Current Assets
$9.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
35%
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Current Assets
CHf7.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
2%
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Current Assets
CHf1.3m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Other Current Assets
CHf298k
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
Glance View
Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
See Also
What is Idorsia Ltd's Other Current Assets?
Other Current Assets
10.9m
CHF
Based on the financial report for Dec 31, 2025, Idorsia Ltd's Other Current Assets amounts to 10.9m CHF.
What is Idorsia Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 3Y
-32%
Over the last year, the Other Current Assets growth was -65%. The average annual Other Current Assets growth rates for Idorsia Ltd have been -32% over the past three years .
